Sign in with Google
bullish
IMNN: Comes to Alignment with FDA Regarding Phase 3 Protocol for IMNN-001
On November 25, 2024, Imunon, Inc. (IMNN) announced it had reached alignment with the U.S. Food and Drug Administration (FDA) on its proposed plan...
What is covered in the Full Insight:
- Business Update
- Phase 3 Trial Plan
- Ovation 2 Trial Results
- Conclusion
- Financial Overview
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »- [Japan Activism] Murakami Owns ~42% and Company Announces 31.3% Buyback
- Henderson Land (12 HK): Large Passive Flow Coming Up as Shorts Cover
- Tam Jai (2217 HK): Anxiety Creeps in Ahead of the Scheme Document
- FXI Rebalance: Pop Mart, SF Holding In; China Merchant Sec, China Railway Out
- Accounting for Soul Patts/Brickworks' Feedback Loop
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Loading...
x